Understanding Bile Acid Diarrhea
Understanding Bile Acid Diarrhea
Understanding Bile Acid Diarrhea
By
Barbara Bolen, PhD
Updated on November 08, 2021
Medically reviewed
by
Robert Burakoff, MD, MPH
Bile acid diarrhea (BAD) is a condition in which bile acids aren't properly processed
by the digestive system. This can cause chronic diarrhea.
BAD may not be as rare as it was once thought to be. The condition might be
underdiagnosed. This may be preventing people from getting treatment.
Some researchers feel anyone with chronic diarrhea of unknown cause should be
evaluated for BAD. This includes people with symptoms of diarrhea-predominant
irritable bowel syndrome (IBS-D) or functional diarrhea, which is recurrent diarrhea
with no known cause.
This article will discuss bile acid diarrhea, its symptoms, and its causes. It will also
discuss diagnosis and treatment of the condition.
Watery diarrhea
Diarrhea that comes on suddenly
Diarrhea in the middle of the night
Soiling accidents
Bloating
Afterward, bile acids are reabsorbed and sent back to the liver for reuse. Typically,
very little bile acid ends up in the large intestine.
In people with BAD, large amounts of bile acid get flushed into the large intestine.
This causes an increase in fluid in the intestine. The movement of fluid through the
intestines speeds up and the result is watery stools.
Related:
Bile Acid Malabsorption and IBS Diarrhea
Testing
Outside the United States, BAD is often diagnosed with a test called a 75-selenium
homotaurocholic acid test (SeHCAT). During this test, the patient swallows a
capsule containing SeHCAT. SeHCAT is a mildly radioactive synthetic bile acid that
shows up on a full-body scan.
Patients undergoing this test receive one scan a few hours after taking the SeHCAT.
A second scan is performed a week later.
The test looks at how well the small intestine retains bile acids. If the retention rate is
lower than 15%, it indicates BAM.
Unfortunately, this test is not available in the United States. Lack of access to the
SeHCAT test may contribute to the underdiagnosis of BAD.
In the United States, stool testing is the most direct way to diagnose BAD. This
requires a 48-hour stool collection to measure bile acids within the colon.
Some doctors use a trial of a medication to treat BAD. If the medication improves
symptoms, BAD is diagnosed.
If your BAD is the result of an identifiable disease, your doctor will treat the disease
itself. If no underlying cause can be identified, BAD is usually treated with
medications called bile acid sequestrants or binders.
Bile acid sequestrants are FDA-approved to treat high blood cholesterol. They are
prescribed off-label to treat BAM.
These medications bind to bile acids and reduce their effects on the large intestine.
This class of drugs includes:
Questran (cholestyramine)
Welchol (colesevelam)
Colestid (colestipol)
Drugs in this class may affect the absorption of other medications. For that reason,
you should take them four to six hours before or after any other medications.
Summary
Bile acid diarrhea is a condition that causes chronic diarrhea. It is caused by excess
bile acid in the large intestine. It may be underdiagnosed. BAD may be the actual
cause of many cases of chronic diarrhea and IBS-D.
Outside the United States, BAM is diagnosed with a SeHCAT scan. In the United
States, doctors rely on stool tests and medication trials to diagnose the condition.
BAM can be treated with medication.
6 Sources
Verywell Health uses only high-quality sources, including peer-reviewed studies, to support the facts
within our articles. Read our editorial process to learn more about how we fact-check and keep our
content accurate, reliable, and trustworthy.
3. Camilleri M. Bile acid diarrhea: prevalence, pathogenesis, and therapy. Gut Liver.
2015;9(3):332. doi:10.5009%2Fgnl14397
4. Lent-Schochet D, Jialal I. Antilipemic agent bile acid sequestrants. In: StatPearls [Internet].
Treasure Island, Fla: StatPearls Publishing; 2020.
5. Oduyebo I, Camilleri M. Bile acid disease: the emerging epidemic. Curr Opin Gastroenterol.
2017;33(3):189-195. doi:10.1097/MOG.0000000000000344
6. Johnston I, Nolan JD, Dew T, Shapiro D, Walters JR. PTU-193 a novel, rational approach to
treating primary bile acid diarrhoea: a proof of concept study of the FXR agonist obeticholic
acid. Gut. 2013;62(Suppl 1):A127-8. doi:10.1136/gutjnl-2013-304907.283
Additional Reading
DiBaise JK, Islam RS. Bile acids: an under-recognized and under-appreciated cause of chronic
diarrhea. Pract Gastroenterol. 2012;36(10):32-44.